These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3900664)

  • 1. Serum neuron-specific enolase in metastatic Merkel cell tumors.
    Giannone L; Johnson DH; Grosh WW; Davis BW; Marangos PJ; Greco FA
    Med Pediatr Oncol; 1985; 13(6):357-62. PubMed ID: 3900664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum levels of neuron-specific enolase.
    Simpson S; Vinik AI; Marangos PJ; Lloyd RV
    Cancer; 1984 Oct; 54(7):1364-9. PubMed ID: 6088026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostaining of neuron-specific enolase as a diagnostic tool for Merkel cell tumors.
    Gu J; Polak JM; Van Noorden S; Pearse AG; Marangos PJ; Azzopardi JG
    Cancer; 1983 Sep; 52(6):1039-43. PubMed ID: 6349776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neuron-specific enolase. A marker for responses to therapy in seminoma.
    Kuzmits R; Schernthaner G; Krisch K
    Cancer; 1987 Sep; 60(5):1017-21. PubMed ID: 2440552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
    Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
    Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.
    Gaiser MR; Daily K; Hoffmann J; Brune M; Enk A; Brownell I
    Oncotarget; 2015 Sep; 6(28):26472-82. PubMed ID: 26299616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A metastatic Merkel cell carcinoma successfully treated with chemotherapy].
    Miyagishima T; Okada K; Nagasaka A; Takano K; Hirano T; Yamazaki Y; Fujimoto N; Higuti A; Yoshida C; Fujita M
    Gan No Rinsho; 1990 Jan; 36(1):75-9. PubMed ID: 2405209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma].
    Guo HB; Stoffel-Wagner B; Brennemann W; Springer W; Klingmüller D
    J Tongji Med Univ; 1995; 15(1):19-25. PubMed ID: 7783258
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
    O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
    Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuron-specific enolase (NSE)--a suitable tumor marker in malignant melanoma?].
    Hornef S; Lux J; Rassner G
    Hautarzt; 1992 Feb; 43(2):77-80. PubMed ID: 1347764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of neurofilament and neuron-specific enolase in small cell tumors of skin using immunohistochemistry.
    Leff EL; Brooks JS; Trojanowski JQ
    Cancer; 1985 Aug; 56(3):625-31. PubMed ID: 2988750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merkel cell carcinoma: a report of three cases with neurone-specific enolase activity.
    Kirkham N; Isaacson P
    Histopathology; 1983 Mar; 7(2):251-9. PubMed ID: 6343216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-specific enolase in neuroendocrine tumors of the thymus, bronchus, and skin.
    Wick MR; Scheithauer BW; Kovacs K
    Am J Clin Pathol; 1983 Jun; 79(6):703-7. PubMed ID: 6303108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merkel cell tumor of the skin: an immunohistochemical study.
    Drijkoningen M; de Wolf-Peeters C; van Limbergen E; Desmet V
    Hum Pathol; 1986 Mar; 17(3):301-7. PubMed ID: 2419238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neuron-specific enolase as a marker of small-cell carcinoma of the esophagus.
    Sasajima K; Watanabe M; Ando T; Hao K; Miyashita M; Yamashita K; Onda M; Takubo K
    J Clin Gastroenterol; 1990 Aug; 12(4):384-8. PubMed ID: 2168912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A neuron-specific enolase (NSE) positive leiomyosarcoma].
    Ueno H; Asami M; Yoneda R; Ogura M; Muraoka A; Oribe T; Suzuki K; Maeda M; Chinzei T; Yamashiro K
    Gan No Rinsho; 1990 Dec; 36(15):2616-22. PubMed ID: 2266593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.
    Cooper EH; Splinter TA; Brown DA; Muers MF; Peake MD; Pearson SL
    Br J Cancer; 1985 Sep; 52(3):333-8. PubMed ID: 2994704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
    Huang Z; Xu D; Zhang F; Ying Y; Song L
    Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
    Nitta T; Fukuoka M; Masuda N; Kusunoki Y; Matsui K; Kudoh S; Hirashima T; Yana T; Ito K; Takada M
    Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.